ANI Pharmaceuticals | ANIP - Current Liabilities

Stock Price
78.64
Daily Change
0.58 0.74%
Monthly
6.17%
Yearly
12.63%
Q2 Forecast
79.14

ANI Pharmaceuticals reported $278.11M in Current Liabilities for its fiscal quarter ending in December of 2025.





Current Liabilities Change Date
AbbVie USD 43.29B 3.9B Dec/2025
ANI Pharmaceuticals USD 278.11M 7.56M Dec/2025
Assertio Holdings USD 166.78M 34.25M Sep/2025
Aurora Cannabis CAD 145.94M 21.82M Dec/2025
Canopy Growth CAD 98.29M 17.19M Dec/2025
Eli Lilly USD 35.23B 4.91B Dec/2025
Emergent BioSolutions USD 651.3M 12.7M Dec/2023
Heron Therapeutics USD 96.1M 6.39M Dec/2025
Hikma Pharmaceutical USD 1.45B 603M Dec/2025
Knight Therapeutics CAD 165.26M 12.58M Dec/2025
Nektar Therapeutics USD 53.54M 12.8M Dec/2025
Novartis USD 27.28B 4.72B Dec/2025
Omeros USD 85.5M 2.28M Jun/2025
Perrigo USD 1.01B 132.4M Dec/2025
Sun Pharmaceuticals INR 234.15B 52.21B Sep/2025
Teva Pharmaceutical Industries USD 13.46B 1.96B Dec/2025